Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachele Frascatani

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancers|December 17, 2024
Hepcidin Is a Valuable Therapeutic Target for Colorectal CancerRachele Frascatani, Marco Colella, Giovanni Monteleone
Journal of Inflammation (London, England)|February 10, 2026
Bromodomain-containing protein 4 in inflammatory diseases: molecular mechanisms and therapeutic potentialRachele Frascatani, Irene Marafini, Marco Colella, et al.
Cancers|May 4, 2026
Immunologic Drivers and Restraints in Colitis-Associated Colorectal CancerRachele Frascatani, Federica Laudisi, Carmine Stolfi, et al.
Nutrients|June 19, 2024
Reduced Taurine Serum Levels in Inflammatory Bowel DiseaseRachele Frascatani, Adelaide Mattogno, Andrea Iannucci, et al.
Frontiers in Pharmacology|November 28, 2025
Bromodomain-containing 4 as a therapeutic target in inflammatory bowel diseases and colorectal cancerIrene Marafini, Rachele Frascatani, Marco Colella, et al.
International Journal of Molecular Sciences|January 28, 2026
Longitudinal Evidence of Sustained Taurine Deficiency in Inflammatory Bowel DiseaseRachele Frascatani, Adelaide Mattogno, Silvia Salvatori, et al.
Cancers|December 17, 2024
Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line TreatmentVincenzo Formica, Antonio Di Grazia, Maria Vittoria Bonomo, et al.
Cells|October 25, 2024
Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the GutEleonora Franzè, Federica Laudisi, Rachele Frascatani, et al.
Oncoimmunology|April 11, 2025
Smad7 is a negative regulator of immunogenic cell death in colorectal cancerClaudia Maresca, Eleonora Franzè, Federica Laudisi, et al.
Experimental Hematology & Oncology|September 28, 2024
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death responseAntonio Di Grazia, Eleonora Franzè, Rachele Frascatani, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancers|December 17, 2024
Hepcidin Is a Valuable Therapeutic Target for Colorectal CancerRachele Frascatani, Marco Colella, Giovanni Monteleone
Journal of Inflammation (London, England)|February 10, 2026
Bromodomain-containing protein 4 in inflammatory diseases: molecular mechanisms and therapeutic potentialRachele Frascatani, Irene Marafini, Marco Colella, et al.
Cancers|May 4, 2026
Immunologic Drivers and Restraints in Colitis-Associated Colorectal CancerRachele Frascatani, Federica Laudisi, Carmine Stolfi, et al.
Nutrients|June 19, 2024
Reduced Taurine Serum Levels in Inflammatory Bowel DiseaseRachele Frascatani, Adelaide Mattogno, Andrea Iannucci, et al.
Frontiers in Pharmacology|November 28, 2025
Bromodomain-containing 4 as a therapeutic target in inflammatory bowel diseases and colorectal cancerIrene Marafini, Rachele Frascatani, Marco Colella, et al.
International Journal of Molecular Sciences|January 28, 2026
Longitudinal Evidence of Sustained Taurine Deficiency in Inflammatory Bowel DiseaseRachele Frascatani, Adelaide Mattogno, Silvia Salvatori, et al.
Cancers|December 17, 2024
Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line TreatmentVincenzo Formica, Antonio Di Grazia, Maria Vittoria Bonomo, et al.
Cells|October 25, 2024
Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the GutEleonora Franzè, Federica Laudisi, Rachele Frascatani, et al.
Oncoimmunology|April 11, 2025
Smad7 is a negative regulator of immunogenic cell death in colorectal cancerClaudia Maresca, Eleonora Franzè, Federica Laudisi, et al.
Experimental Hematology & Oncology|September 28, 2024
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death responseAntonio Di Grazia, Eleonora Franzè, Rachele Frascatani, et al.
Pageof 2